Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot

Abstract

Prolonged maintenance of therapeutically-relevant levels of broadly neutralizing antibodies (bnAbs) is necessary to enable passive immunization against infectious disease.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2023
Source ID
10.1039/d2bm00819j

Entities

People

  • Abigail E. Powell
  • Anthony C. Yu
  • Awua Buahin
  • Caitlin Maikawa
  • Carolyn K. Jons
  • Catherine M Meis
  • Celine S Liong
  • Eric A Appel
  • Gillie Agmon
  • Jacob E. Glanville
  • Sawsan Youssef
  • Xueting Zhou

Organizations

  • Gates Foundation
  • National Institute of Allergy and Infectious Diseases
  • National Science Foundation
  • Stanford University